XML 42 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-Based Compensation (Tables)
3 Months Ended
Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense is included in the consolidated results of operations as follows (in thousands):
 
Three months ended December 31,
 
2015
 
2014
Cost of sales
$
54

 
$
65

Sales and marketing
199

 
338

Research and development
148

 
154

General and administrative
410

 
525

Stock-based compensation before income taxes
811

 
1,082

Income tax benefit
(257
)
 
(422
)
Stock-based compensation after income taxes
$
554

 
$
660

Schedule of Stock Option Activity
The following table summarizes our stock option activity (in thousands, except per common share amounts):
 
 
Options Outstanding
 
Weighted Average Exercised Price
 
Weighted Average Contractual Term (in years)
 
Aggregate Intrinsic Value (1)
Balance at September 30, 2015
 
4,800

 
$10.21
 
 
 
 
Granted
 
348

 
12.63
 
 
 
 
Exercised
 
(611
)
 
9.83
 
 
 
 
Forfeited / Canceled
 
(426
)
 
11.52
 
 
 
 
Balance at December 31, 2015
 
4,111

 
$10.34
 
4.9
 
$
6,304

 
 
 
 
 
 
 
 
 
Exercisable at December 31, 2015
 
2,935

 
$10.49
 
4.0
 
$
4,223

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, based on our closing stock price of $11.38 as of December 31, 2015, which would have been received by the option holders had all option holders exercised their options as of that date. The intrinsic value of an option is the amount by which the fair value of the underlying stock exceeds its exercise price.
Schedule of Valuation Assumptions
The table below shows the weighted average fair value, which was determined based upon the fair value of each option on the grant date utilizing the Black-Scholes option-pricing model and the related assumptions:
 
Three months ended December 31,
 
2015
 
2014
Weighted average per option grant date fair value
$4.30
 
$2.91
Assumptions used for option grants:
 
 
 
Risk free interest rate
1.85%
 
1.77% - 1.85%
Expected term
6.00 years
 
6.00 years
Expected volatility
32%
 
35% - 36%
Weighted average volatility
32%
 
35%
Expected dividend yield
0
 
0
Schedule of Nonvested Restricted Stock Units
A summary of our non-vested restricted stock units as of December 31, 2015 and changes during the three months then ended is presented below (in thousands, except per common share amounts):
 
Number of Awards
 
Weighted Average Grant Date Fair Value
Nonvested at September 30, 2015
543

 
$
8.41

Granted
121

 
$
12.63

Vested
(104
)
 
$
7.79

Canceled
(91
)
 
$
8.11

Nonvested at December 31, 2015
469

 
$
9.69